Equbits

Equbits was a biotechnology software company that specialized in applying advanced machine learning techniques to drug discovery. Founded in 2001, the company developed the Equbits Foresight platform, which utilized Support Vector Machines (SVM) to predict the biological activity and ADMET properties of small molecules. Their technology was designed to assist pharmaceutical researchers in building robust Quantitative Structure-Activity Relationship (QSAR) models to streamline lead optimization. By automating the creation of predictive models, Equbits aimed to accelerate the drug development process and reduce the high failure rates associated with clinical trials. Although a pioneer in the AI-driven drug discovery space, the company is no longer active. The firm's work laid early groundwork for the integration of sophisticated statistical learning into the medicinal chemistry workflow.